Cargando…
Determination of a prediction model for therapeutic response and prognosis based on chemokine signaling-related genes in stage I–III lung squamous cell carcinoma
Background: The chemokine signaling pathway plays an essential role in the development, progression, and immune surveillance of lung squamous cell carcinoma (LUSC). Our study aimed to systematically analyze chemokine signaling-related genes (CSRGs) in LUSC patients with stage I–III disease and devel...
Autores principales: | Lai, Jinzhi, Yang, Shiyu, Chu, Shuqiang, Xu, Tianwen, Huang, Jingshan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9470854/ https://www.ncbi.nlm.nih.gov/pubmed/36118890 http://dx.doi.org/10.3389/fgene.2022.921837 |
Ejemplares similares
-
Determination of a DNA repair-related gene signature with potential implications for prognosis and therapeutic response in pancreatic adenocarcinoma
por: Lai, Jinzhi, et al.
Publicado: (2022) -
Comprehensive molecular characterizations of stage I–III lung adenocarcinoma with tumor spread through air spaces
por: Ye, Ronghao, et al.
Publicado: (2023) -
A Combined RNA Signature Predicts Recurrence Risk of Stage I-IIIA Lung Squamous Cell Carcinoma
por: Sun, Li, et al.
Publicado: (2021) -
Pegylated Liposomal Doxorubicin Versus Epirubicin as Adjuvant Therapy for Stage I–III Breast Cancer
por: Hu, Wenxian, et al.
Publicado: (2021) -
The association between plasma chemokines and breast cancer risk and prognosis: A mendelian randomization study
por: Yu, Xingxing, et al.
Publicado: (2023)